Furthermore, all GLP1RA CVOTs showed noninferiority for cardiovascular safety compared with placebo
Third culture cuisine: beyond fusion The report notes that Global Fusion is becoming deeply personal
Most people with treated hypothyroidism can safely use GLP-1 or GLP-1/GIP medications under medical supervision, provided they do not have certain rare thyroid cancer risks
SURMOUNT-1 Trial Data for Tirzepatide The SURMOUNT-1 trial (N=2,539) tested tirzepatide, a dual GIP/GLP-1 receptor agonist, in adults with obesity but without type 2 diabetes
Very recently, direct-immunofluorescence microscopy of rat lower hindlimb muscles revealed that with aging, extracellular matrix (ECM)-bound HGF undergoes tyrosine residue (Y) nitration, as visualized by anti-nitrated Y-HGF monoclonal antibodies (mAbs, rat clones 3A11C6 and 6B82C3 raised in-house) in experiments employing three age-groups of young (2-month-old), adult (10-month-old), and old rats (20-month-old) 32
10.1016/j.schres.2012.03.017 8